基于网络药理学的三味檀香散治疗冠心病的机制初探
孙雨辉;陆景坤;王健;王跃武;张谦;范蕾;那生桑;贾宇臣
【期刊名称】《中国新药与临床杂志》 【年(卷),期】2018(037)005
【摘要】AIM To explore the molecular mechanisms and potential active ingredients of the MongolianSanwei Tanxiang powder on coronary heart disease (CHD).METHODS The chemical composition in Sanwei Tanxiang powder was collected by literature mining and Chinese herbal medicine composition database retrieval, and analyzed by oral bioavailability (OB) and drug-likeness (DL) screening.The potential targets of the compound were predicted by online platform of Pharm Mapper, SWISS and Superpred.The related targets of CHD were collected by OMIM database.Protein interaction was analyzed by STRING.The pathway of key target was predicted by the DAVID online tool.The formula of \prescriptions-targets-CHD network model\and\network model\were established by Cytoscape software, and topology analysis of network model was carried out.The results of the analysis of network model were verified by Schrodinger molecular docking technique.RESULTS The results of network pharmacology showed that the biological pathways related to in the pathogenesis of CHD caused by Sanwei Tanxiang powder may be involved in stress response, angiogenesis, immune
inflammatory response, cell damage, apoptosis and necrosis, endocrine regulation, cell division and proliferation, atherosclerosis and arterial plaque instability.Cellular tumor antigen p53, adenosine receptor A1, RAC-alpha serine/threonine-protein kinase, E3 ubiquitin-protein ligase mdm2, etc.were likely to be the key target of Sanxiang Tanxiang powder for CHD.CONCLUSION Sanxiang Tanxiang powder may regulate multiple biological pathways in the development of CHD through the main composition and multiple target protein function, such as stress response, angiogenesis, immune inflammatory response, energy metabolism, endocrine regulation, etc.%目的 探讨蒙药三味檀香散治疗冠心病的分子作用机制和潜在活性成分.方法 通过文献挖掘、多个中药材成分数据库检索收集整理三味檀香散中化学成分, 并经口服生物利用度 (OB) 和类药性 (DL) 分析筛选.利用Pharm Mapper、SWISS、Superpred在线平台预测化合物潜在靶点, OMIM数据库收集冠心病的相关靶标.利用STRING做蛋白互作分析, 通过DAVID在线工具对关键靶标做通路富集.应用Cytoscape软件建立该方剂的\方剂-靶点-冠心病药物网络模型\和\方剂-化合物-靶点-通路网络模型\并对网络模型进行拓扑学分析.采用Schrodinger分子对接技术对网络模型分析部分结果进行验证.结果网络药理学结果表明, 蒙药方剂三味檀香散与冠心病发病机制相关的生物学途径主要有应激反应、血管新生、免疫炎症反应、细胞损伤、凋亡及坏死、内分泌调节、细胞分裂增殖、动脉粥样硬化、动脉斑块的不稳定性.TP53、ADORA1、AKT1、MDM2等靶点可能是三味檀香散治疗冠心病的关键靶点.结论 三味檀香散可能通过其主要成分与多个靶点蛋白作用, 调控冠心
病发展过程中的应激反应、血管生成、免疫炎症反应、能量代谢、内分泌调节等多条生物通路治疗冠心病. 【总页数】18页(272-289)
【关键词】蒙药;冠心病;药理作用分子作用机制;拓扑学;三味檀香散;网络药理学 【作者】孙雨辉;陆景坤;王健;王跃武;张谦;范蕾;那生桑;贾宇臣
【作者单位】内蒙古医科大学药学院,内蒙古 呼和浩特 010059;内蒙古医科大学基础医学院,内蒙古 呼和浩特 010059;沈阳药科大学基于靶点的药物设计与研究教育部重点实验室,辽宁 沈阳 110016;内蒙古医科大学临床前药物安全评价中心,内蒙古 呼和浩特 010059;内蒙古医科大学临床前药物安全评价中心,内蒙古 呼和浩特 010059;内蒙古医科大学药学院,内蒙古 呼和浩特 010059;内蒙古医科大学蒙医药研究院,内蒙古 呼和浩特 010059;内蒙古医科大学基础医学院,内蒙古 呼和浩特 010059 【正文语种】中文 【中图分类】R972 【文献来源】
https://www.zhangqiaokeyan.com/academic-journal-cn_chinese-journal-new-drugs-clinical-remedies_thesis/0201241831139.html 【相关文献】
1.基于网络药理学和生物信息学的丹参酮ⅡA治疗冠心病的分子生物学机制分析 [J], 徐文华; 郑景辉; 赵阳; 赵新望; 董音汝; 李丽
2.基于网络药理学的二陈汤治疗冠心病分子机制研究 [J], CHEN Wen-na; ZHU Ai-song; CONG Pei-wei; GUO Jun-fu; WANG Dan; WANG Jun-yan
基于网络药理学的三味檀香散治疗冠心病的机制初探
